Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 4 | W1C831M | SC / RA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Y013579 | SC / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | CX4HL | IM / LA |
On October 1, 2024 clinic received a shipment of COVID vaccine that needed to be stored in the freezer. There was no room in the freezer to accommodate the shipment. The following document was found on the FDA website: file:///U:Package-Insert-Refrigerator-Stable-Formulation-Proquad.pdf. It was assumed that ProQuad could be stored in both the freezer and refrigerator and both State and Private ProQuad were moved to the refrigerators where they remained within normal refrigerated temperature range until administration. The dose of MMRV administered to this client was received on November 13, 2024 and stored in the refrigerator until administered on January 8, 2025.